Pharmavite Amends CholestOff Claims After FTC Joins Heart Health Hunt
This article was originally published in The Tan Sheet
Executive Summary
An attorney for Pharmavite questions federal regulators' apparent pursuit of cholesterol-lowering products after the firm satisfies a Federal Trade Commission investigation by revising marketing language for its CholestOff dietary supplement
You may also be interested in...
CSPI Expects Pfizer’s Centrum Claim Changes To Resonate Across Industry
Pfizer will discontinue advertising claims for Centrum Ultra Women’s and Silver Women’s multivitamin supplements for “breast health” and Centrum Ultra Men’s and Silver Ultra Men’s for “colon health.”
CSPI Expects Pfizer’s Centrum Claim Changes To Resonate Across Industry
Pfizer will discontinue advertising claims for Centrum Ultra Women’s and Silver Women’s multivitamin supplements for “breast health” and Centrum Ultra Men’s and Silver Ultra Men’s for “colon health.”
FDA Cheerios Warning Signals Tougher Stance On Health Claims Enforcement
FDA's warning letter to General Mills concerning cardiovascular health claims linked to Cheerios reflects a newly empowered agency and foreshadows aggressive regulatory activity to come, experts say